Cargando…
The σ1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia Under NMDA Receptor Negative Control
Aims: The in vivo pharmacology of the sigma 1 receptor (σ1R) is certainly complex; however, σ1R antagonists are of therapeutic interest, because they enhance mu-opioid receptor (MOR)-mediated antinociception and reduce neuropathic pain. Thus, we investigated whether the σ1R is involved in the negati...
Autores principales: | Rodríguez-Muñoz, María, Sánchez-Blázquez, Pilar, Herrero-Labrador, Raquel, Martínez-Murillo, Ricardo, Merlos, Manuel, Vela, José Miguel, Garzón, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367239/ https://www.ncbi.nlm.nih.gov/pubmed/25557043 http://dx.doi.org/10.1089/ars.2014.5993 |
Ejemplares similares
-
The σ1 Receptor and the HINT1 Protein Control α2δ1 Binding to Glutamate NMDA Receptors: Implications in Neuropathic Pain
por: Rodríguez-Muñoz, María, et al.
Publicado: (2021) -
The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders
por: Rodríguez-Muñoz, María, et al.
Publicado: (2015) -
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity
por: Vicente-Sánchez, Ana, et al.
Publicado: (2013) -
(α)N-Acetyl β-Endorphin Is an Endogenous Ligand of σ1Rs That Regulates Mu-Opioid Receptor Signaling by Exchanging G Proteins for σ2Rs in σ1R Oligomers
por: Garzón-Niño, Javier, et al.
Publicado: (2022) -
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
por: Rodríguez-Muñoz, María, et al.
Publicado: (2016)